1st Quarter - Report

LOPER CONSULTING LLC for TEVA PHARMACEUTICALS USA

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S 2948 Medicaid Generic Drug Price Fainess Act H.R.1353 PATIENT Act of 2015 Lobbied on issues related to abuse deterrent formulations of drugs and prescription drug abuse FDA proposed rule on generic drug labels

LobbyistCovered position, as disclosed
GINGER LOPER special assistant to the President 2002-2005

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1353 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.